Nanoform will be attending PODD, which is a virtual meeting this year. The event promises to uphold its ten-year tradition of combining partnering with access to cutting-edge business and scientific content in the field of drug delivery, with loyal support from a top-notch speaking faculty. PODD offers access to a wide range of drug delivery technologies and opens partnering before during and after the event.
Edward Haeggstrom, CEO will be hosting a Fireside chat with Shawn Davis, Head of Drug Delivery, Biopharmaceuticals Development at AstraZeneca. In this session, we will learn about the journey being undertaken to help pharma and biotech partners reduce attrition in clinical trials and enhance their molecules’ formulation performance through proprietary nanotechnology.
Eric Peter, VP US Business development will also be delivering a talk title ”Small is transformative: nanoparticle solutions for drug delivery innovation’’. This talk will delve into the human trial results for the world’s first nanoformed drug, and discuss the ongoing industry collaborations investigating how nanoparticle engineering can facilitate drug delivery innovation to ultimately benefit patients.
Get in touch to arrange a meeting.